AAAAAA

   
Results: 1-25 |
Results: 25

Authors: Pittet, MJ Speiser, DE Valmori, D Rimoldi, D Lienard, D Lejeune, F Cerottini, JC Romero, P
Citation: Mj. Pittet et al., Ex vivo analysis of tumor antigen specific CD8(+) T cell responses using MHC/peptide tetramers in cancer patients, INT IMMUNO, 1(7), 2001, pp. 1235-1247

Authors: Romero, P Dutoit, V Rubio-Godoy, V Lienard, D Speiser, D Guillaume, P Servis, K Rimoldi, D Cerottini, JC Valmori, D
Citation: P. Romero et al., CD8(+) T-cell response to NY-ESO-1: Relative antigenicity and in vitro immunogenicity of natural and analogue sequences, CLIN CANC R, 7(3), 2001, pp. 766S-772S

Authors: Pittet, MJ Speiser, DE Lienard, D Valmori, D Guillaume, P Dutoit, V Rimoldi, D Lejeune, F Cerottini, JC Romero, P
Citation: Mj. Pittet et al., Expansion and functional maturation of human tumor antigen-specific CD8(+)T cells after vaccination with antigenic peptide, CLIN CANC R, 7(3), 2001, pp. 796S-803S

Authors: Rubio-Godoy, V Dutoit, V Rimoldi, D Lienard, D Lejeune, F Speiser, D Guillaume, P Cerottini, JC Romero, P Valmori, D
Citation: V. Rubio-godoy et al., Discrepancy between ELISPOT IFN-gamma secretion and binding of A2/peptide multimers to TCR reveals interclonal dissociation of CTL effector function from TCR-peptide/MHC complexes half-life, P NAS US, 98(18), 2001, pp. 10302-10307

Authors: Burlando, SC Paz, LA De Feo, LG Benchetrit, G Rimoldi, D Predari, SC
Citation: Sc. Burlando et al., Ovarian abscess due to Actinomyces sp in absence of an intrauterine contraceptive device., MEDICINA, 61(5), 2001, pp. 577-580

Authors: Rimoldi, D Muehlethaler, K Salvi, S Valmori, D Romero, P Cerottini, JC Levy, F
Citation: D. Rimoldi et al., Subcellular localization of the melanoma-associated protein Melan-A(MART-1) influences the processing of its HLA-A2-restricted epitope, J BIOL CHEM, 276(46), 2001, pp. 43189-43196

Authors: Berset, M Cerottini, JP Guggisberg, D Romero, P Burri, F Rimoldi, D Panizzon, RG
Citation: M. Berset et al., Expression of Melan-A/MART-1 antigen as a prognostic reactor in primary cutaneous melanoma, INT J CANC, 95(1), 2001, pp. 73-77

Authors: Valmori, D Dutoit, V Rubio-Godoy, V Chambaz, C Lienard, D Guillaume, P Romero, P Cerottini, JC Rimoldi, D
Citation: D. Valmori et al., Frequent cytolytic T-cell responses to peptide IMAGE-A10(254-262) in melanoma, CANCER RES, 61(2), 2001, pp. 509-512

Authors: Dutoit, V Rubio-Godoy, V Dietrich, PY Quiqueres, AL Schnuriger, V Rimoldi, D Lienard, D Speiser, D Guillaume, P Batard, P Cerottini, JC Romero, P Valmori, D
Citation: V. Dutoit et al., Heterogeneous T-cell response to MAGE-A10(254-262): High avidity-specific cytolytic T lymphocytes show superior antitumor activity, CANCER RES, 61(15), 2001, pp. 5850-5856

Authors: Rimoldi, D Rubio-Godoy, V Dutoit, V Lienard, D Salvi, S Guillaume, P Speiser, D Stockert, E Spagnoli, G Servis, C Cerottini, JC Lejeune, F Romero, P Valmori, D
Citation: D. Rimoldi et al., Efficient simultaneous presentation of NY-ESO-1/LAGE-1 primary and nonprimary open reading frame-derived CTL epitopes in melanoma, J IMMUNOL, 165(12), 2000, pp. 7253-7261

Authors: Valmori, D Dutoit, V Lienard, D Lejeune, F Speiser, D Rimoldi, D Cerundolo, V Dietrich, PY Cerottini, JC Romero, P
Citation: D. Valmori et al., Tetramer-guided analysis of TCR beta-chain usage reveals a large repertoire of melan-A-specific CD8(+) T cells in melanoma patients, J IMMUNOL, 165(1), 2000, pp. 533-538

Authors: Valmori, D Levy, F Miconnet, I Zajac, P Spagnoli, GC Rimoldi, D Lienard, D Cerundolo, V Cerottini, JC Romero, P
Citation: D. Valmori et al., Induction of potent antitumor CTL responses by recombinant vaccinia encoding a Melan-A peptide analogue, J IMMUNOL, 164(2), 2000, pp. 1125-1131

Authors: Berard, F Blanco, P Davoust, J Neidhart-Berard, EM Nouri-Shirazi, M Taquet, N Rimoldi, D Cerottini, JC Banchereau, J Palucka, AK
Citation: F. Berard et al., Cross-priming of naive CD8 T cells against melanoma antigens using dendritic cells loaded with killed allogeneic melanoma cells, J EXP MED, 192(11), 2000, pp. 1535-1543

Authors: Rimoldi, D Salvi, S Schultz-Thater, E Spagnoli, GC Cerottini, JC
Citation: D. Rimoldi et al., Anti-MAGE-3 antibody 57B and anti-MAGE-1 antibody 6C1 can be used to studydifferent proteins of the MAGE-A family, INT J CANC, 86(5), 2000, pp. 749-751

Authors: Valmori, D Dutoit, V Lienard, D Rimoldi, D Pittet, MJ Champagne, P Ellefsen, K Sahin, U Speiser, D Lejeune, F Cerottini, JC Romero, P
Citation: D. Valmori et al., Naturally occurring human lymphocyte antigen-A2 restricted CD8+T-cell response to the cancer testis antigen NY-ESO-1 in melanoma patients, CANCER RES, 60(16), 2000, pp. 4499-4506

Authors: Valmori, D Fonteneau, JF Valitutti, S Gervois, N Dunbar, R Lienard, D Rimoldi, D Cerundolo, V Jotereau, F Cerottini, JC Speiser, DE Romero, P
Citation: D. Valmori et al., Optimal activation of tumor-reactive T cells by selected antigenic peptideanalogues, INT IMMUNOL, 11(12), 1999, pp. 1971-1979

Authors: Valmori, D Gervois, N Rimoldi, D Fonteneau, JF Bonelo, A Lienard, D Rivoltini, L Jotereau, F Cerottini, JC Romero, P
Citation: D. Valmori et al., Diversity of the fine specificity displayed by HLA-A0201-restricted CTL specific for the immunodominant Melan-A/MART-1. (vol 161, pg 6956, 1998), J IMMUNOL, 163(2), 1999, pp. 1093-1093

Authors: Men, Y Miconnet, I Valmori, D Rimoldi, D Cerottini, JC Romero, P
Citation: Y. Men et al., Assessment of immunogenicity of human melan-A peptide analogues in HLA-A0201/K-b transgenic mice, J IMMUNOL, 162(6), 1999, pp. 3566-3573

Authors: Speiser, DE Pittet, MJ Valmori, D Dunbar, R Rimoldi, D Lienard, D MacDonald, HR Cerottini, JC Cerundolo, V Romero, P
Citation: De. Speiser et al., In vivo expression of natural killer cell inhibitory receptors by human melanoma-specific cytolytic T lymphocytes, J EXP MED, 190(6), 1999, pp. 775-782

Authors: Serrano, A Lethe, B Delroisse, JM Lurquin, C De Plaen, E Brasseur, F Rimoldi, D Boon, T
Citation: A. Serrano et al., Quantitative evaluation of the expression of MAGE genes in tumors by limiting dilution of cDNA libraries, INT J CANC, 83(5), 1999, pp. 664-669

Authors: Rimoldi, D Salvi, S Reed, D Coulie, P Jongeneel, VC De Plaen, E Brasseur, F Rodriguez, AM Boon, T Cerottini, JC
Citation: D. Rimoldi et al., cDNA and protein characterization of human MAGE-10, INT J CANC, 82(6), 1999, pp. 901-907

Authors: Speiser, DE Valmori, D Rimoldi, D Pittet, MJ Lienard, D Cerundolo, V MacDonald, HR Cerottini, JC Romero, P
Citation: De. Speiser et al., CD28-negative cytolytic effector T cells frequently express NK receptors and are present at variable proportions in circulating lymphocytes from healthy donors and melanoma patients, EUR J IMMUN, 29(6), 1999, pp. 1990-1999

Authors: Valmori, D Pittet, MJ Rimoldi, D Lienard, D Dunbar, R Cerundolo, V Lejeune, F Cerottini, JC Romero, P
Citation: D. Valmori et al., An antigen-targeted approach to adoptive transfer therapy of cancer, CANCER RES, 59(9), 1999, pp. 2167-2173

Authors: Valmori, D Pittet, MJ Vonarbourg, C Rimoldi, D Lienard, D Speiser, D Dunbar, R Cerundolo, V Cerottini, JC Romero, P
Citation: D. Valmori et al., Analysis of the cytolytic T lymphocyte response of melanoma patients to the naturally HLA-A0201-associated tyrosinase peptide 368-376, CANCER RES, 59(16), 1999, pp. 4050-4055

Authors: Valmori, D Gervois, N Rimoldi, D Fonteneau, JF Bonelo, A Lienard, D Rivoltini, L Jotereau, F Cerottini, JC Romero, P
Citation: D. Valmori et al., Diversity of the fine specificity displayed by HLA-A0201-restricted CTL specific for the immunodominant Melan-A/MART-1 antigenic peptide, J IMMUNOL, 161(12), 1998, pp. 6956-6962
Risultati: 1-25 |